文献速递神经肿瘤

经蝶手术患者标准化跨学科围手术期方案的实施:对患者结局的影响

Implementation of a Standardized Interdisciplinary Perioperative Protocol for Patients Undergoing Transsphenoidal Surgery: Impact on Patient Outcomes.
PubMed 文献 · World Neurosurg · 2024-07-30

该研究比较了2016至2022年间279例接受内镜下经鼻蝶垂体手术患者(方案前128例、方案后151例)的围手术期特征与术后结局,方案于2021年1月实施,包括跨学科术前评估、统一沟通、术后糖皮质激素替代的皮质醇阈值及限制液体预防延迟性低钠血症;方案后第1天出院比例从46.1%升至74.2%(P<0.0001),急诊就诊和再入院率下降,结论认为该方案可缩短住院时间并减少再入院和手术相关并发症。

要点

  • 方案后第1天出院比例74.2%,方案前46.1%(P<0.0001)。
  • 低钠血症方案前13.3%,方案后4.6%;急诊就诊9.4%降至3.9%,再入院7.8%降至2.6%。
  • 暂时性精氨酸加压素缺乏方案前10.4%,方案后4.6%(P=0.101)。

核心结论

  • 实施跨学科围手术期方案可缩短经蝶内镜垂体手术患者的住院时间,同时减少再入院和手术相关并发症。

研究设计与样本

  • 本研究为单中心比较性研究,纳入2016年至2022年间接受内镜下经蝶垂体手术的279例患者,其中方案前128例、方案后151例,方案于2021年1月实施。

主要发现

  • 中位年龄54±17岁,女性占50.8%;大腺瘤(>1 cm)229例(82.1%),微腺瘤/囊肿(<1 cm)50例(17.9%)。
  • 平均直径:横径18 mm、头尾径18 mm、前后径16 mm。
  • 肿瘤类型:促性腺激素细胞腺瘤125例(44.8%)、促肾上腺皮质激素细胞腺瘤46例(16.4%)、催乳素细胞腺瘤40例(14.3%)、Rathke囊肿26例(9.3%)、生长激素细胞腺瘤19例(6.8%)、非诊断性13例(4.6%)、生长激素-催乳素细胞腺瘤3例(1%)、乳腺生长激素细胞腺瘤3例(1%)、零细胞腺瘤2例(0.71%)、促甲状腺激素细胞腺瘤2例(0.7%)。
  • 方案后第1天出院比例为74.2%,方案前为46.1%(P<0.0001)。
  • 暂时性精氨酸加压素缺乏从方案前10.4%降至方案后4.6%(P=0.101);低钠血症方案前13.3%、方案后4.6%;急诊就诊从9.4%降至3.9%;再入院从7.8%降至2.6%;持续性精氨酸加压素缺乏方案前2.3%、方案后1.3%;脑脊液漏方案前8.5%、方案后7.3%。

关键数值与推荐

  • 方案包括跨学科术前评估、统一沟通、术后糖皮质激素替代的皮质醇阈值以及限制液体以预防延迟性低钠血症。

临床怎么用

  • 作者认为,实施跨学科围手术期方案可缩短住院时间并减少再入院和手术相关并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Advances in endoscopic endonasal transsphenoidal surgery have led to improved postoperative outcomes after pituitary adenoma resection, including reduced length of stay, complications and readmission rates, without compromising safety and satisfaction. METHODS: Our team implemented a perioperative protocol in January 2021 for patients undergoing endoscopic, transsphenoidal pituitary surgery. This study compares preoperative characteristics and postoperative outcomes in 279 patients between 2016 and 2022 (128 preprotocol and 151 postprotocol). Our protocol includes interdisciplinary preoperative evaluations, unified communication, cortisol thresholds for postoperative glucocorticoid replacement, and fluid restriction to prevent delayed hyponatremia. RESULTS: Median age was 54 ± 17 years with 50.8% female patients. There were 229 (82.1%) macroadenomas (>1 cm) and 50 (17.9%) microadenomas/cysts (<1 cm). Mean diameter was 18 (transverse), 18 (craniocaudal), 16 (anteroposterior) mm. Tumor types included 125 (44.8%) gonadotroph, 46 (16.4%) adrenocorticotroph, 40 (14.3%) lactotroph, 26 (9.3%) Rathke cysts, 19 (6.8%) somatotroph, 13 (4.6%) nondiagnostic, 3 (1%) somatotroph-lactotroph, 3 (1%) mammosomatotroph, 2 (0.71%) null cell, and 2 (0.7%) thyrotroph adenomas. Postprotocol, 74.2% of patients were discharged on postoperative day 1 compared with 46.1% preprotocol (P < 0.0001). Transient arginine vasopressin deficiency decreased from 10.4% (preprotocol) to 4.6% postprotocol (P = 0.101). Hyponatremia occurred in 13.3% pre-protocol and 4.6% postprotocol. Emergency department visits dropped from 9.4% to 3.9%, and readmissions decreased from 7.8% to 2.6%. Persistent arginine vasopressin deficiency affected 2.3% preprotocol and 1.3% postprotocol patients. Cerebrospinal fluid leaks occurred in 8.5% preprotocol and 7.3% postprotocol. CONCLUSIONS: Implementing an interdisciplinary, perioperative protocol for transsphenoidal endoscopic pituitary surgery improves length of stay while minimizing readmissions and surgery-related complications.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sanchez-Garavito JE, Perez-Vega C, Iyer H, et al. Implementation of a Standardized Interdisciplinary Perioperative Protocol for Patients Undergoing Transsphenoidal Surgery: Impact on Patient Outcomes. World Neurosurg. 2024. PMID: 39084288. doi:10.1016/j.wneu.2024.07.128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。